1	New	New	B-NP	JJ	O	2	NMOD	-1
2	vectors	vector	I-NP	NNS	O	4	NMOD	-1
3	and	and	I-NP	CC	O	4	NMOD	-1
4	strategies	strategy	I-NP	NNS	O	0	ROOT	-1
5	for	for	B-PP	IN	O	4	NMOD	-1
6	cardiovascular	cardiovascular	B-NP	JJ	O	8	NMOD	-1
7	gene	gene	I-NP	NN	O	8	NMOD	-1
8	therapy	therapy	I-NP	NN	O	5	PMOD	0
9	.	.	O	.	O	4	P	-1

1	Cardiovascular	Cardiovascular	B-NP	JJ	O	2	NMOD	-1
2	diseases	disease	I-NP	NNS	O	3	SUB	-1
3	are	be	B-VP	VBP	O	0	ROOT	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	major	major	I-NP	JJ	O	6	NMOD	-1
6	cause	cause	I-NP	NN	O	3	PRD	-1
7	of	of	B-PP	IN	O	6	NMOD	-1
8	morbidity	morbidity	B-NP	NN	O	10	NMOD	-1
9	and	and	I-NP	CC	O	10	NMOD	-1
10	mortality	mortality	I-NP	NN	O	7	PMOD	-1
11	in	in	B-PP	IN	O	6	NMOD	-1
12	both	both	B-NP	CC	O	15	NMOD	-1
13	men	man	I-NP	NNS	O	15	NMOD	-1
14	and	and	I-NP	CC	O	15	NMOD	-1
15	women	woman	I-NP	NNS	O	11	PMOD	-1
16	in	in	B-PP	IN	O	15	NMOD	-1
17	industrially	industrially	B-NP	RB	O	18	AMOD	-1
18	developed	develop	I-NP	VBN	O	19	NMOD	0
19	countries	country	I-NP	NNS	O	16	PMOD	-1
20	.	.	O	.	O	3	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	disorders	disorder	I-NP	NNS	O	3	SUB	-1
3	may	may	B-VP	MD	O	0	ROOT	-1
4	result	result	I-VP	VB	O	3	VC	-1
5	from	from	B-PP	IN	O	4	VMOD	-1
6	impaired	impaired	B-NP	JJ	O	7	NMOD	18	impaired
7	angiogenesis	angiogenesis	I-NP	NN	O	5	PMOD	3	angiogenesis
8	,	,	O	,	O	4	P	-1
9	particularly	particularly	B-ADVP	RB	O	10	PMOD	-1
10	in	in	B-PP	IN	O	4	VMOD	-1
11	response	response	B-NP	NN	O	10	PMOD	0
12	to	to	B-PP	TO	O	11	NMOD	-1
13	hypoxia	hypoxia	B-NP	NN	O	12	PMOD	-1
14	.	.	O	.	O	3	P	-1

1	Despite	Despite	B-PP	IN	O	7	VMOD	-1
2	many	many	B-NP	JJ	O	3	NMOD	-1
3	limitations	limitation	I-NP	NNS	O	1	PMOD	-1
4	,	,	O	,	O	7	P	-1
5	gene	gene	B-NP	NN	O	6	NMOD	-1
6	therapy	therapy	I-NP	NN	O	7	SUB	0
7	is	be	B-VP	VBZ	O	0	ROOT	-1
8	still	still	I-VP	RB	O	7	VMOD	-1
9	emerging	emerge	I-VP	VBG	O	7	VMOD	-1
10	as	as	B-PP	IN	O	9	VMOD	-1
11	a	a	B-NP	DT	O	13	NMOD	-1
12	potential	potential	I-NP	JJ	O	13	NMOD	0
13	alternative	alternative	I-NP	NN	O	10	PMOD	-1
14	for	for	B-PP	IN	O	13	NMOD	-1
15	patients	patient	B-NP	NNS	O	14	PMOD	-1
16	who	who	B-NP	WP	O	15	NMOD	-1
17	are	be	B-VP	VBP	O	16	SBAR	-1
18	not	not	O	RB	O	17	VMOD	-1
19	candidates	candidate	B-NP	NNS	O	18	PMOD	-1
20	for	for	B-PP	IN	O	19	NMOD	-1
21	traditional	traditional	B-NP	JJ	O	23	NMOD	-1
22	revascularization	revascularization	I-NP	NN	O	23	NMOD	3	revascularization
23	procedures	procedure	I-NP	NNS	O	20	PMOD	-1
24	,	,	O	,	O	19	P	-1
25	like	like	B-PP	IN	O	19	NMOD	-1
26	angioplasty	angioplasty	B-NP	JJ	O	29	NMOD	-1
27	or	or	I-NP	CC	O	29	NMOD	-1
28	vein	vein	I-NP	NN	O	29	NMOD	-1
29	grafts	graft	I-NP	NNS	O	25	PMOD	-1
30	.	.	O	.	O	7	P	-1

1	This	This	B-NP	DT	O	2	NMOD	-1
2	review	review	I-NP	NN	O	3	SUB	-1
3	focuses	focus	B-VP	VBZ	O	0	ROOT	-1
4	on	on	B-PP	IN	O	3	VMOD	-1
5	recent	recent	B-NP	JJ	O	6	NMOD	-1
6	approaches	approach	I-NP	NNS	O	4	PMOD	-1
7	in	in	B-PP	IN	O	6	NMOD	-1
8	the	the	B-NP	DT	O	9	NMOD	-1
9	development	development	I-NP	NN	O	7	PMOD	0
10	of	of	B-PP	IN	O	9	NMOD	-1
11	new	new	B-NP	JJ	O	14	NMOD	-1
12	gene	gene	I-NP	NN	O	14	NMOD	-1
13	delivery	delivery	I-NP	NN	O	14	NMOD	0
14	vectors	vector	I-NP	NNS	O	10	PMOD	-1
15	,	,	O	,	O	3	P	-1
16	with	with	B-PP	IN	O	3	VMOD	-1
17	great	great	B-NP	JJ	O	18	NMOD	-1
18	respect	respect	I-NP	NN	O	27	NMOD	-1
19	to	to	B-PP	TO	O	18	NMOD	-1
20	newly	newly	B-NP	RB	O	21	AMOD	-1
21	discovered	discover	I-NP	VBN	O	23	NMOD	-1
22	AAV	AAV	I-NP	NN	O	23	NMOD	-1
23	serotypes	serotype	I-NP	NNS	O	19	PMOD	-1
24	and	and	O	CC	O	27	NMOD	-1
25	their	their	B-NP	PRP$	O	27	NMOD	-1
26	modified	modified	I-NP	JJ	O	27	NMOD	-1
27	forms	form	I-NP	NNS	O	16	PMOD	-1
28	.	.	O	.	O	3	P	-1

1	Moreover	Moreover	B-ADVP	RB	O	9	VMOD	-1
2	,	,	O	,	O	9	P	-1
3	some	some	B-NP	DT	O	8	NMOD	-1
4	new	new	I-NP	JJ	O	8	NMOD	-1
5	cardiovascular	cardiovascular	I-NP	JJ	O	8	NMOD	-1
6	gene	gene	I-NP	NN	O	8	NMOD	-1
7	therapy	therapy	I-NP	NN	O	8	NMOD	0
8	strategies	strategy	I-NP	NNS	O	9	SUB	-1
9	have	have	B-VP	VBP	O	0	ROOT	-1
10	been	be	I-VP	VBN	O	9	VC	-1
11	highlighted	highlight	I-VP	VBN	O	10	VC	-1
12	,	,	O	,	O	11	P	-1
13	such	such	B-PP	JJ	O	14	PMOD	-1
14	as	as	I-PP	IN	O	11	VMOD	-1
15	combination	combination	B-NP	NN	O	14	PMOD	-1
16	of	of	B-PP	IN	O	15	NMOD	-1
17	different	different	B-NP	JJ	O	23	NMOD	-1
18	angiogenic	angiogenic	I-NP	JJ	B-protein	20	NMOD	3	angiogenic
19	growth	growth	I-NP	NN	I-protein	20	NMOD	0
20	factors	factor	I-NP	NNS	I-protein	17	NMOD	-1
21	or	or	O	CC	O	17	NMOD	-1
22	simultaneous	simultaneous	B-NP	JJ	O	23	NMOD	-1
23	application	application	I-NP	NN	O	16	PMOD	0
24	of	of	B-PP	IN	O	23	NMOD	-1
25	genes	gene	B-NP	NNS	O	28	NMOD	-1
26	and	and	O	CC	O	28	NMOD	-1
27	progenitor	progenitor	B-NP	NN	B-cell_type	28	NMOD	-1
28	cells	cell	I-NP	NNS	I-cell_type	24	PMOD	-1
29	in	in	B-SBAR	IN	O	15	NMOD	-1
30	order	order	O	NN	O	29	DEP	-1
31	to	to	B-VP	TO	O	32	VMOD	-1
32	obtain	obtain	I-VP	VB	O	29	SBAR	2	obtain
33	stable	stable	B-NP	JJ	O	37	NMOD	-1
34	and	and	I-NP	CC	O	37	NMOD	-1
35	functional	functional	I-NP	JJ	O	37	NMOD	-1
36	blood	blood	I-NP	NN	O	37	NMOD	-1
37	vessels	vessel	I-NP	NNS	O	32	OBJ	-1
38	in	in	B-PP	IN	O	32	VMOD	-1
39	ischemic	ischemic	B-NP	JJ	O	40	NMOD	-1
40	tissue	tissue	I-NP	NN	O	38	PMOD	-1
41	.	.	O	.	O	9	P	-1

